The marine biotechnology market is projected to grow from $5.79 billion in 2023 to $8.28 billion in 2028 at a CAGR of 7.3%, driven by factors like climate change mitigation and product innovations. Europe leads the market, with key players including Cyanotech Corporation and PharmaMar S.A.